Whereas Basal-like and HER2-enriched cancers exhibit little to no expression of estrogen receptor (ER) and ER-related genes, both Luminal A and Luminal B subtypes are characterized by expression and activity of ER (5). The gene discussed is ESR1; the disease is cancer.